Certara, Inc.
AI-powered pharmacokinetic and clinical trial simulation software for drug development
- Sector
- Biotech
- Headquarters
- RADNOR, PA
- Founded
- 2017
- Latest Form D
- $8.6M, Apr 2026
- Total capital
- $14.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $14.3M
- 4 Form D · last Apr 2026
- 6 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 19 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$8.6M
- Private capital raisedForm D · SEC · 1st filing$5.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
2 records have no date or no amount, so they aren’t placed on the timeline.
Standing in Biotech · 4373 companies
Line = median- Federal contractsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Adrian McKemeyExecutive OfficerNamed in SEC Form D filings
- Arjun BediDirectorNamed in SEC Form D filings
- Carol G. GallagherDirectorNamed in SEC Form D filings
- Craig R. RaynerExecutive OfficerNamed in SEC Form D filings
- Cynthia CollinsDirectorNamed in SEC Form D filings
- Daniel CorcoranExecutive OfficerNamed in SEC Form D filings
Show all 31 people
- David SpaightDirectorNamed in SEC Form D filings
- Eran BroshyDirectorNamed in SEC Form D filings
- Eric C. LiuDirectorNamed in SEC Form D filings
- Ethan P. WaxmanDirectorNamed in SEC Form D filings
- James CashmanDirectorNamed in SEC Form D filings
- James E. Cashman IIIDirectorNamed in SEC Form D filings
- Jieun W. ChoeExecutive OfficerNamed in SEC Form D filings
- John Gallagher IIIExecutive OfficerNamed in SEC Form D filings
- John ReyndersDirectorNamed in SEC Form D filings
- Jon ResnickExecutive Officer, DirectorNamed in SEC Form D filings
- Justin W. EdgeExecutive OfficerNamed in SEC Form D filings
- Leif PedersenExecutive OfficerNamed in SEC Form D filings
- Mason P. SlaineDirectorNamed in SEC Form D filings
- Matthew WalshDirectorNamed in SEC Form D filings
- Michael Andrew SchemickExecutive OfficerNamed in SEC Form D filings
- Nancy KilleferDirectorNamed in SEC Form D filings
- Nicolette ShermanExecutive OfficerNamed in SEC Form D filings
- Patrick SmithExecutive OfficerNamed in SEC Form D filings
- Richard TraynorExecutive OfficerNamed in SEC Form D filings
- Robert AspburyExecutive OfficerNamed in SEC Form D filings
- Rona AnhaltExecutive OfficerNamed in SEC Form D filings
- Rosemary CraneDirectorNamed in SEC Form D filings
- Sherilyn S. McCoyExecutive OfficerNamed in SEC Form D filings
- Stephen McLeanDirectorNamed in SEC Form D filings
- William FeeheryExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 19- PendingGraphical User Interface For Providing Automated, Real-time Interactive Word Processing Assistance To A UserUSPTOApplication 18804930
- PendingMachine-learning Models To Create, Update, Validate, And/or Assess The Comprehensiveness Of A Mechanistic Model Of Biological SystemsUSPTOApplication 18804983
- PendingMethods And Apparatus Utilising Liquid Biopsy To Identify And Monitor Pharmacodynamic Markers Of DiseaseUSPTOApplication 18431820
Show all 19 patent records
- Graphical User Interface For Providing Automated, Real-time Interactive Word Processing Assistance To A UserFeb 20, 2025 · Application 18804930Pending
- Machine-learning Models To Create, Update, Validate, And/or Assess The Comprehensiveness Of A Mechanistic Model Of Biological SystemsFeb 20, 2025 · Application 18804983Pending
- Methods And Apparatus Utilising Liquid Biopsy To Identify And Monitor Pharmacodynamic Markers Of DiseaseJun 20, 2024 · Application 18431820Pending
- Methods And Apparatus For Identifying Organ/tissue Health Status Using Transcriptomics Analysis Of Liquid Biopsy SamplesJul 7, 2022 · Application 17656299Pending
- Methods And Apparatus For Generating A Virtual Model Of Xenobiotic Exposure Using Transcriptomics Analysis Of Liquid Biopsy SamplesJul 7, 2022 · Application 17656302Pending
- Data Searching System And MethodJan 6, 2022 · Application 17477069Pending
- Methods And Apparatus For Quantifying Protein Abundance In Tissues Via Cell Free Ribonucleic Acids In Liquid BiopsyFeb 4, 2021 · Application 17032498Pending
- Systems And Methods For Predicting And Adjusting The Dosage Of Medicines In Individual PatientsNov 17, 2016 · Application 14164828Pending
- Machine-learning Models To Create, Update, Validate, And/or Assess The Comprehensiveness Of A Mechanistic Model Of Biological SystemsApplication 63533282Pending
- Graphical User Interface For Providing Automated, Real-time Interactive Word Processing Assistance To A UserApplication 63533274Pending
- Graphical User Interface For Providing Automated, Real-time Interactive Word Processing Assistance To A UserApplication 63660449Pending
- Graphical User Interface For Providing Automated, Real-time Interactive Word Processing Assistance To A UserApplication PCTUS2024042268Pending
- Methods And Apparatus For Identifying Organ/tissue Health Status Using Transcriptomics Analysis Of Liquid Biopsy SamplesApplication PCTUS2020052208Pending
- Methods And Apparatus For Generating A Virtual Model Of Xenobiotic Exposure Using Transcriptomics Analysis Of Liquid Biopsy SamplesApplication PCTUS2020052261Pending
- Methods And Apparatus For Generating A Virtual Model Of Xenobiotic Exposure Using Transcriptomics Analysis Of Liquid Biopsy SamplesApplication 62905885Pending
- Methods And Apparatus For Identifying Organ/tissue Health Status Using Transcriptomics Analysis Of Liquid Biopsy SamplesApplication 62905952Pending
- Methods And Apparatus For Quantifying Protein Abundance In Tissues Via Cell Free Ribonucleic Acids In Liquid BiopsyApplication PCTUS2019024379Pending
- Methods For Quantifying Cell Free Ribonucleic Acids In BloodApplication 62648984Pending
- Machine-learning Models To Create, Update, Validate, And/or Assess The Comprehensiveness Of A Mechanistic Model Of Biological SystemsApplication PCTUS2024042317Pending
Related companies, and why
- KINETA, INC.Similar federal contract value in Biotech · null in contracts
- JuvoBio Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
- ReplimuneSimilar federal contract value in Biotech · null in contracts
- SOYMEDS INCSimilar federal contract value in Biotech · null in contracts
- RAFT PHARMACEUTICALS LLCSimilar federal contract value in Biotech · null in contracts
- PLUREXA LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .